AGO TUMOR NO FURTHER A MYSTERY

If lymph node involvement is proven in the affected person undergoing neoadjuvant therapy who is a possible prospect for focused axillary dissection (TAD), a marker needs to be inserted during the lymph node right after biopsy.Important is the exact documentation in the tumor place prior to, for the duration of and soon after NST (LoE 5D AGO ++). S